Combioxin

Risk score

57
Large logo of Combioxin

Headquarters

Flag of SwitzerlandSwitzerland

Combioxin is a Switzerland-based biotech firm committed to developing pioneering life-saving medications for serious infections. The organization is presently conducting two concurrent initiatives using an original technology tailored to combat severe bacterial and viral infections. Combioxin strives to emerge as a leader in unconventional treatments for severe and resilient infections.